ADMA vs CB · P/E 22, rev $426.5M vs P/E 14, rev $59.40B
ADMA Biologics Inc (ADMA) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported ADMA revenue for 2024-12-31 was $426.5M. Net income was $197.7M. Revenue was up 65.2% from 2023-12-31 to 2024-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the ADMA and CB stock pages for the full models.
Not investment advice.